Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55B Sell
12,073,109
-293,824
-2% -$34.4M 2.06% 14
2026
Q1
$1.49B Sell
12,366,933
-1,721,772
-12% -$199M 1.98% 15
2025
Q4
$1.48B Buy
14,088,705
+4,265,097
+43% +$400M 1.87% 18
2025
Q3
$824M Buy
9,823,608
+692,290
+8% +$57M 1.32% 31
2025
Q2
$723M Buy
9,131,318
+1,661,958
+22% +$132M 1.18% 32
2025
Q1
$670M Buy
7,469,360
+1,224,910
+20% +$114M 1.13% 33
2024
Q4
$621M Buy
6,244,450
+3,301,429
+112% +$340M 0.82% 41
2024
Q3
$334M Buy
+2,943,021
New +$350M 0.44% 52
2015
Q2
Sell
-24,979
Closed -$1.37M 155
2015
Q1
$1.37M Buy
24,979
+3,853
+18% +$218K ﹤0.01% 135
2014
Q4
$1.15M Buy
21,126
+711
+3% +$39.6K ﹤0.01% 146
2014
Q3
$1.16M Hold
20,415
﹤0.01% 144
2014
Q2
$1.13M Sell
20,415
-28,849
-59% -$1.57M ﹤0.01% 144
2014
Q1
$2.67M Sell
49,264
-1,838,131
-97% -$95.2M ﹤0.01% 127
2013
Q4
$90.1M Buy
1,887,395
+120,185
+7% +$5.49M 0.16% 100
2013
Q3
$80.3M Buy
1,767,210
+2,480
+0.1% +$113K 0.16% 104
2013
Q2
$78.2M Buy
+1,764,730
New +$78.8M 0.16% 106

Other funds holding MRK

Bill Nygren's MRK Position: Q2 2026 in Review

Bill Nygren reduced its Merck (MRK) stake by 2.4% in Q2 2026, selling an estimated $34.4M and leaving 12,073,109 shares worth $1.55B. The position accounts for 2.06% of the portfolio, ranked #14.

Bill Nygren first reported a position in MRK in Q2 2013 and has held it in 16 quarters since. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bill Nygren held 12,073,109 shares of Merck worth $1.55B as of Q2 2026.
  • Bill Nygren sold 293,824 Merck shares in Q2 2026, an estimated $34.4M.
  • Merck made up 2.06% of Bill Nygren's portfolio in Q2 2026, its #14 holding.
  • Bill Nygren first reported a position in Merck in Q2 2013 and has held it in 16 quarters since.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Harris Associates's 13F filing for Q2 2026, filed 14 Aug 2026.